... to compare the efficacy of plitidepsin in combination with dexamethasone vs. dexamethasone alone measured by progression-free survival (PFS) and to evaluate tumor response, duration of response (DR), overall survival (OS) and to rule out any effect of plitidepsin on the duration of the QT/QTc interval (time corresponding to the beginning of depolarization to re-polarization of the ventricles).
*.- ClinicalTrials Identifier: NCT01102426 .
*.- Updated: 2014_01_31 .
*.- Study Start Date: June 2010 .
*.- Estimated Study Completion Date: June 2014 .
*.- Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure) .
*.- ClinicalTrials Identifier: NCT01102426 .